5-F(2t)-isoprostane, a human hormone?

Journal of the American Chemical Society

Volumn 121, Issue 34, 1999, Pages 7773-7777

  Taber, Douglass F ^a   Kanai, Kazuo ^a   Pina, Richard ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; ISOPROSTANE DERIVATIVE; TRIACYLGLYCEROL LIPASE;

ARTICLE; CATALYSIS; CHEMICAL REACTION; DIASTEREOISOMER; ENANTIOMER; ENZYME CHEMISTRY; RACEMIC MIXTURE; SYNTHESIS;

EID: 0033198636     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja990859k     Document Type: Article

References (43)

1. Morrow, J. D.; Hill, K. E.; Burk, R. F.; Nammour, T. M.; Badr, K. F.; Roberts, L. J., II. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 9383.
2. (a) For a summary of isoprostane nomenclature, see Taber, D. F.; Morrow, J. D.; Roberts, L. J., II. Prostaglandins 1997, 53, 63. (b) For an alternative nomenclature system for the isoprostanes, see Rokach, J.; Khanapure, S. P.; Hwang, S. W.; Adiyaman, M.; Lawson, J. A.; FitzGerald, G. A. Prostaglandins 1997, 54, 853.
3. (a) For a summary of isoprostane nomenclature, see Taber, D. F.; Morrow, J. D.; Roberts, L. J., II. Prostaglandins 1997, 53, 63. (b) For an alternative nomenclature system for the isoprostanes, see Rokach, J.; Khanapure, S. P.; Hwang, S. W.; Adiyaman, M.; Lawson, J. A.; FitzGerald, G. A. Prostaglandins 1997, 54, 853.
4. Morrow, J. D.; Minton, T. A.; Mukundan, C. R.; Campbell, M. D.; Zackert, W. E.; Daniel, V. C.; Badr, K. F.; Blair, I. A.; Roberts, L. J., II. J. Biol. Chem. 1994, 269, 4317.
5. Morrow, J. D.; Roberts, L. J., II. Biochem. Pharmacol. 1996, 51, 1.
6. 2t-isoprostane: (a) Corey, E. J.; Shih, C.; Shih, N.-Y.; Shimoji, K. Tetrahedron Lett. 1984, 25, 5013. (b) Hwang, S. W.; Adiyaman, M.; Khanapure, S.; Schio, L.; Rokach, J. J. Am. Chem. Soc. 1994, 116, 10829. (c) Taber, D. F.; Herr, R. J.; Gleave, D. M. J. Org. Chem. 1997, 62, 194. (d) Taber, D. F.; Kanai, K. Tetrahedron 1998, 54, 11767.
7. 2t-isoprostane: (a) Corey, E. J.; Shih, C.; Shih, N.-Y.; Shimoji, K. Tetrahedron Lett. 1984, 25, 5013. (b) Hwang, S. W.; Adiyaman, M.; Khanapure, S.; Schio, L.; Rokach, J. J. Am. Chem. Soc. 1994, 116, 10829. (c) Taber, D. F.; Herr, R. J.; Gleave, D. M. J. Org. Chem. 1997, 62, 194. (d) Taber, D. F.; Kanai, K. Tetrahedron 1998, 54, 11767.
8. 2t-isoprostane: (a) Corey, E. J.; Shih, C.; Shih, N.-Y.; Shimoji, K. Tetrahedron Lett. 1984, 25, 5013. (b) Hwang, S. W.; Adiyaman, M.; Khanapure, S.; Schio, L.; Rokach, J. J. Am. Chem. Soc. 1994, 116, 10829. (c) Taber, D. F.; Herr, R. J.; Gleave, D. M. J. Org. Chem. 1997, 62, 194. (d) Taber, D. F.; Kanai, K. Tetrahedron 1998, 54, 11767.
9. 2t-isoprostane: (a) Corey, E. J.; Shih, C.; Shih, N.-Y.; Shimoji, K. Tetrahedron Lett. 1984, 25, 5013. (b) Hwang, S. W.; Adiyaman, M.; Khanapure, S.; Schio, L.; Rokach, J. J. Am. Chem. Soc. 1994, 116, 10829. (c) Taber, D. F.; Herr, R. J.; Gleave, D. M. J. Org. Chem. 1997, 62, 194. (d) Taber, D. F.; Kanai, K. Tetrahedron 1998, 54, 11767.
10. 2c-isoprostane: (a) Larock, R. C.; Lee, N. H. J. Am. Chem. Soc. 1991, 113, 7815. (b) Vionnet, J.-P.; Renaud, P. Helv. Chim. Acta 1994, 77, 1781. (c) Hwang, S. W.; Adiyaman, M.; Khanapure, S. P.; Rokach, J. Tetrahedron Lett, 1996, 37, 779.
11. 2c-isoprostane: (a) Larock, R. C.; Lee, N. H. J. Am. Chem. Soc. 1991, 113, 7815. (b) Vionnet, J.-P.; Renaud, P. Helv. Chim. Acta 1994, 77, 1781. (c) Hwang, S. W.; Adiyaman, M.; Khanapure, S. P.; Rokach, J. Tetrahedron Lett, 1996, 37, 779.
12. 2c-isoprostane: (a) Larock, R. C.; Lee, N. H. J. Am. Chem. Soc. 1991, 113, 7815. (b) Vionnet, J.-P.; Renaud, P. Helv. Chim. Acta 1994, 77, 1781. (c) Hwang, S. W.; Adiyaman, M.; Khanapure, S. P.; Rokach, J. Tetrahedron Lett, 1996, 37, 779.
13. 2t-isoprostane: Taber, D. F.; Hoerrner, R. S. J. Org. Chem. 1992, 57, 441. (b) See also ref 5d.
14. 2t-isoprostane: Taber, D. F.; Hoerrner, R. S. J. Org. Chem. 1992, 57, 441. (b) See also ref 5d.
15. 2t-isoprostane: Adiyaman, M.; Lawson, J. A.; Hwang, S.-W.; Khanapure, S. P.; FitzGerald, G. A.; Rokach, J. Tetrahedron Lett. 1996, 37, 4849.
16. 2c-isoprostane: Adiyaman, M.; Lawson, J. A.; FitzGerald, G. A.; Rokach, J. Tetrahedron Lett. 1998, 39, 7039.
17. 2t-isoprostane: Adiyaman, M.; Li, H.; Lawason, J. A.; Hwang, S.-W.; Khanapure, S. P.; FitzGerald, G. A.; Rokach, J. Tetrahedron Lett. 1997, 38, 3339.
18. 2t-isoprostane: Pudukulathan, Z.; Manna, S.; Hwang, S.-W.; Khanapure, S. P.; Lawson, J. A.; FitzGerald, G. A.; Rokach, J. J. Am. Chem. Soc. 1998, 120, 11953.
19. (a) Morrow, J. D.; Minton, T. A.; Roberts, L. J., II. Prostaglandins 1992, 44, 155.
20. (b) Fukunaga, M.; Makita, N.; Roberts, L. J., II.; Morrow, J. D.; Takahashi, K.; Badr, K. F. Am. J. Physiol (Cell Physiol. 33) 1993, 264, C1619.
21. (c) Takahashi, K.; Nammour, T. M.; Fukunaga, M.; Ebert, J.; Morrow, J. D.; Roberts, L. J., II; Hoover, R. L.; Badr, F. K. J. Clin. Invest. 1992, 990, 136.
22. (d) Longmire, A. W.; Roberts, L. J., II.; Morrow, J. D. Prostaglandins 1994, 48, 247.
23. (e) Fukunaga, M.; Takahashi, K.; Badr, K. F. Biochem. Biophys. Res. Commun. 1993, 195, 507.
24. Taber, D. F.; Louey, J. P. Tetrahedron 1995, 51, 4495.
25. Taber, D. F.; Gleave, D. M.; Herr, R. J.; Moody, K.; Hennessy, M. J. J. Org. Chem. 1995, 60, 2283.
26. Hosoda, A.; Taguchi, T.; Kobayashi, Y. Tetrahedron Lett. 1987, 28, 65.
27. Ethyl 5-oxopentanoate was prepared by ethanolysis of δ-valerolactone followed by PCC oxidation. For full characterization, see Penn, J. H.; Liu, F. J. Org. Chem. 1994, 59, 2608.
28. For a complementary approach to the methyl esters of 19 and 10, see Pohnert, G.; Boland, W. Tetrahedron 1996, 52, 10073.
29. 13C chemical shifts of allylic methylenes, see Taber, D. F.; You, K. J. Org. Chem. 1995, 60, 139 and references therein.
30. 4, the unstable tetraene resulting from β-hydride elimination was the major product.
31. (a) Charles, R. G. J. Org. Chem. 1957, 22, 677.
32. (b) Sacconi, L.; Ciampolini, M. J. Chem. Soc. 1964, 276.
33. (c) Corey, E. J.; Myers, A. G. Tetrahedron Lett. 1984, 25, 3559.
34. Taber, D. F.; Kanai, K. J. Org. Chem. 1998, 63, 6607.
35. (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
36. (b) Ireland, R. E.; Liu, L. J. Org. Chem. 1993, 58, 2899.
37. Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemistry; Pergamon Press: Oxford, U.K., 1994; and references therein.
38. (a) Bickart, P.; Carson, F. W.; Jacobus, J.; Miller, E. J.; Mislow, K. J. Am. Chem. Soc. 1968, 90, 4869.
39. (b) Tang, R.; Mislow, K. J. Am. Chem. Soc. 1970, 92, 2100.
40. (a) Becker, H.-D.; Björk, A.; Alder, E. J. Org. Chem. 1980, 45, 1596.
41. (b) Tsubuki, M.; Kanai, K.; Keino, K.; Kakinuma, N.; Honda, T. J. Org. Chem. 1992, 57, 2930.
42. The ee's were determined by HPLC analyses with a CHIRALCEL OD column (Daicel Chemical Industries Ltd.): detector, UV (254 nm); flow rate, 1 mL/min; mobile phase, hexane/2-PrOH = 95/5 for 45 and 45b, hexane/2-PrOH = 99/1 for 48 and 48a.
43. Noyori, R.; Tomino, I.; Tanimoto, Y.; Nishizawa, M. J. Am. Chem. Soc. 1984, 106, 6709.